Catalyst Wire Dossier Catalyst Wire Dossier

Olodaterol (BI 1744 CL)

olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olodaterol (BI 1744 CL), covering 2014-06-30 to 2014-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing